Clinical Trial Update: Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating atezolizumab plus tiragolumab in patients with non-small cell lung cancer or advanced solid tumors who previously received a PD-1 inhib…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Solid Tumors

Drugs mentioned

• Tecentriq (atezolizumab)
• Tiragolumab (tiragolumab)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Non-Small Cell Lung Cancer, Solid Tumor | Phase 2 | Status: COMPLETED | Results posted: 2025-08-27